Volume 12 Number 11/12 November/December 2011
1 December 2011. Related: Editorial.
2011
13th European AIDS Conference (EACS), Belgrade, Serbia, 12-15 October 2011
1 December 2011. Related: Conference reports.
European guidelines (EACS) – 2011 update
1 December 2011. Related: Conference reports, Guidelines.
Raltegravir achieves superiority over efavirenz after four years
1 December 2011. Related: Conference reports, Antiretrovirals.
Higher plasma levels of tenofovir and darunavir but not efavirenz in older patients
1 December 2011. Related: Conference reports, PK and drug interactions.
Ritonavir levels reduced with high fat meal
1 December 2011. Related: Conference reports, PK and drug interactions, Nutrition.
Transplacental transfer of raltegravir and delayed plasma clearance in preterm neonates
1 December 2011. Related: Conference reports, Pregnancy.
2nd International Workshop on HIV and Ageing, Baltimore, Maryland, 27-28 October 2011
1 December 2011. Related: Conference reports.
Statin blocks negative impact of PIs on bone formation in vitro
1 December 2011. Related: Conference reports, Antiretrovirals.
HIV linked to frailty in middle-aged IDUs, especially with poor HIV control
1 December 2011. Related: Conference reports, Coinfections and complications.
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Chicago, 17-20 September 2011
1 December 2011. Related: Conference reports.
Monitoring kidney function change with cobicistat
1 December 2011. Related: Conference reports, PK and drug interactions.
Intracellular raltegravir concentrations better with twice-daily than once-daily dosing
1 December 2011. Related: Conference reports, Antiretrovirals.
Rilpivirine (Edurant) and rilpivirine/FTC/tenofovir FDC (Eviplera) approved in Europe
1 December 2011. Related: Antiretrovirals.
FDA updates US label for darunavir for serious rash
1 December 2011. Related: Antiretrovirals.
FDA updates US label for raltegravir due to serious rash
1 December 2011. Related: Antiretrovirals.
Lopinavir concentrations suboptimal at reduced dose of lopinavir/ritonavir 200/50 mg twice daily
1 December 2011. Related: Antiretrovirals, PK and drug interactions.
Switching to 50mg ritonavir dose for selected protease inhibitors
1 December 2011. Related: Antiretrovirals, PK and drug interactions.
New formulations, acquisitions and company announcements
1 December 2011. Related: Antiretrovirals.
Iranian doctors now freed
1 December 2011. Related: Other news.
New York court rejects AIDS denialist case against leading HIV community activist and journalist
1 December 2011. Related: Other news.
UK ban on HIV-positive doctors and dentists set to be overturned
1 December 2011. Related: Other news.
We Were Here
1 December 2011. Related: Book and film reviews.
US guidelines (DHHS) update recommendations for first-line combinations (October 2011)
1 December 2011. Related: Antiretrovirals.
Global Fund cancels Round 11 and introduces new rules for grant renewals
1 December 2011. Related: Treatment access.
Cure research: report from research workshop
1 December 2011. Related: Cure-related research, On the web.
Free full text online articles
1 December 2011. Related: On the web.
FDA approval of generic ARVs
1 December 2011. Related: Treatment access.
We need the Patent Pool to work
1 December 2011. Related: Treatment access.
Efavirenz under-dosing in children
1 December 2011. Related: Paediatric care.
Treatment response and duration of first line treatment in European infants
1 December 2011. Related: Paediatric care.
US guidelines for management of older people living with HIV (2011)
1 December 2011. Related: Coinfections and complications.
New studies on HIV and the diseases of ageing
1 December 2011. Related: Coinfections and complications.
Risk of cataract surgery higher in HIV positive compared to HIV negative people
1 December 2011. Related: Coinfections and complications.
CD4 count <200 independently associated with 5-fold increased risk of fracture
1 December 2011. Related: Coinfections and complications.
Exercise as immune-based therapy
1 December 2011. Related: Basic science and immunology.
Mapping the long genetic road to broadly neutralising antibodies
1 December 2011. Related: Basic science and immunology.
Monkey viral reservoir study goes for gold
1 December 2011. Related: Basic science and immunology.
Immune pressure on HIV
1 December 2011. Related: Basic science and immunology.
Lymphocyte production capacity in HIV: links to immune activation & immune reconstitution on ART
1 December 2011. Related: Basic science and immunology.
International PrEP study (VOICE) discontinues use of tenofovir vaginal gel due to lack of efficacy
1 December 2011. Related: HIV prevention and transmission.
UK Health Protection Agency (HPA) recommends universal HIV testing in the high incidence regions of the UK
1 December 2011. Related: HIV prevention and transmission.
Volume 12 Number 11/12 November/December 2011 PDF
1 December 2011. Related: PDFs.
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 17-20 July 2011, Rome
1 October 2011. Related: Conference reports.
Cure research and viral reservoirs
1 October 2011. Related: Conference reports, Cure-related research, Basic science and immunology.
Orange Farm circumcision results dispel concerns about risk compensation
1 October 2011. Related: Conference reports, HIV prevention and transmission.
Randomised trial of ART in TB patients with high CD4 counts
1 October 2011. Related: Conference reports, TB coinfection.
Once-daily nevirapine approved in Europe
1 October 2011. Related: Antiretrovirals.
Fixed-dose combination of rilpivirine/tenofovir/FTC (Eviplera) recommended for approval in Europe
1 October 2011. Related: Antiretrovirals.
ViiV withdraw European application for once-daily maraviroc
1 October 2011. Related: Antiretrovirals.
FDA approval of generic ARVs
1 October 2011. Related: Treatment access.
Increased risk of preterm delivery with protease inhibitor based HAART in Mma Bana
1 October 2011. Related: Pregnancy.
Global Fund adopts restructuring recommendations and close to 50% funding shortfall for next round of grants
1 October 2011. Related: Treatment access.
Efavirenz in pregnancy: update of systemic review and meta-analysis
1 October 2011. Related: Pregnancy.
AZT not equivalent to HAART to prevent mother-to-child transmission in a Botswana programme
1 October 2011. Related: Pregnancy.
Increased risk of HIV transmission to HIV negative partners during pregnancy
1 October 2011. Related: Pregnancy.
Pharmacokinetics of paediatric tenofovir based regimens
1 October 2011. Related: Paediatric care.
Atazanavir pharmacokinetics in infants, children and adolescents
1 October 2011. Related: Paediatric care.
Crushing lopinavir/ritonavir tablets decreases exposure by almost half in children
1 October 2011. Related: Paediatric care.
WHO Guidelines on guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
1 October 2011. Related: TB coinfection.
IPT for adults: Should the Mantoux test have been removed from WHO guidelines?
1 October 2011. Related: TB coinfection.
DSMB stops oral tenofovir monotherapy arm of VOICE PrEP study due to lack of difference compared to placebo
1 October 2011. Related: HIV prevention and transmission.
i-Base phoneline and information request services: review of service use: 2004-2011
1 October 2011. Related: Other news.
Job vacancy: i-Base administrator
1 October 2011. Related: Job vacancies.
Volume 12 Number 9/10 September/October 2011 PDF
1 October 2011. Related: PDFs.